Effects of inhibitors of protein and ribonucleic acid synthesis on naphthyliso-thiocyanate-induced hyperbilirubinemia, sulfobromophthalein retention and prolongation of pentobarbital hypnosis.
D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003513:Cycloheximide / Q000494:pharmacology*; D003609:Dactinomycin / Q000494:pharmacology*; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005001:Ethionine / Q000494:pharmacology*; D005260:Female; D006932:Hyperbilirubinemia / Q000139:chemically induced / Q000378:metabolism*; D008297:Male; D010424:Pentobarbital / Q000494:pharmacology*; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D012737:Sex Factors; D012890:Sleep / Q000187:drug effects*; D013448:Sulfobromophthalein / Q000378:metabolism*; D013861:Thiocyanates / Q000037:antagonists & inhibitors; D013997:Time Factors
D013861:Thiocyanates; D013448:Sulfobromophthalein; D003609:Dactinomycin; D012313:RNA; D003513:Cycloheximide; D010424:Pentobarbital; D005001:Ethionine